State Street SPDR标普生技ETF XBI 深 沪
等待开盘 04-01 09:30:00 美东时间
127.73
+8.950
+7.53%
华盛通- 最 高127.95
- 今 开122.88
- 成交量 1847.73万股
- 最 低 122.74
- 昨 收 118.78
- 总市值 82.39亿
- 52周最高 132.09
- 市盈率 静 --
- 换手率 28.65%
- 52周最低 73.4945
- 委 比 65.90%
- 总股本 6450.00万
- 历史最高 174.155
- 量 比 1.74
- 振 幅 4.39%
- 历史最低 42.6828
- 每 手 1
- 风险率 18.79%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多BridgeBio Pharma Eyes First Treatment For Rare Muscle Disorder As Trial Data Shows Early Progress
BridgeBio Pharma shares Phase 3 trial update, but early data show progress for rare muscle disease treatment.
03-12 19:47
美股盘后 | VERTIV HOLDINGS LLC涨5.47%，Corebridge Financial, Inc.涨4.34%
VERTIV HOLDINGS LLC涨5.47%；Corebridge Financial, Inc.涨4.34%；回声星通信涨4.00%
03-07 07:11
FDA Makes U-Turn Again On Moderna New Flu Vaccine Review, Stock Soars
Moderna's mRNA-1010 flu vaccine clears FDA review, with stock rising ahead of major approvals.
02-19 02:20
PTC Therapeutics Pulls Translarna Bid After FDA Flags Weak Proof
PTC Therapeutics, Inc. (PTCT) stock closed lower following the withdrawal of its New Drug Application for Translarna by the FDA.
02-13 19:18
Moderna, Mexico Partner To Boost Local Vaccine Production
Moderna signs a long-term deal with Mexico to build local mRNA production, transfer technology, and supply up to 10 million COVID vaccine doses for the 2025–2026 campaign.
02-11 01:26
Moderna (MRNA) Stock Pulls Back After Recent Strength
Moderna shares are down on Monday, pulling back following a recent report highlighting its latest cancer trial results.
01-27 00:15
Moderna Stock Explodes To New 52-Week High: What's Driving The Action?
Moderna Inc (NASDAQ: MRNA) stock is trading higher Thursday morning, hitting a new 52-week high after new cancer trial data.
01-22 23:51
Equities Surge, Commodities Sink As ETF Investors Streamline Portfolio For 2026
ETF flows show investors piling into equity ETFs while pulling money from commodities, leverage and macro trades as they streamline portfolios for 2026.
01-07 03:58
As AI Valuations Stretch, Health Care ETFs Step Into The Growth Spotlight
Health care ETFs are positioned to benefit this year from weight-loss drug growth and defensive appeal as investors rotate away from AI stocks.
01-07 02:09
The Year-End 2025 Biotech Rally And What It Means For 2026
Biotechnology stocks are wrapping up 2025 on a high note, bouncing back from a ...
2025-12-31 23:54
